Pacific Biosciences Of Califor
PACB
$1.225+0.01 (+0.41%)
Jun 26, 2025, 12:30 PM
Financials
| 52Week High | 2.72 | 52Week Low | 0.85 |
| Beta | 2.14 | Current Ratio Annual | 7.48 |
| Current Ratio Quarterly | 6.68 | Gross Margin TTM | 19.49 |
| Market Cap | 366.10M | Net Profit Margin TTM | -431.71 |
| Operating Margin TTM | -438.10 | Price To Book | 4.00 |
| Price To Sales TTM | 2.40 | Quick Ratio Annual | 6.31 |
| Quick Ratio Quarterly | 5.64 | Return On Assets TTM | -51.78 |
| Return On Equity TTM | -170.40 | Return On Investment TTM | -56.90 |
| Revenue Growth3Y | 5.68 | Revenue Growth5Y | 11.12 |
| Revenue Growth Quarterly Yoy | -4.27 | Revenue Growth TTMYoy | -23.98 |
| Revenue Per Share TTM | 0.51 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 228 | 3 | 2 | 6 | 3 | 2 | 264.26M | $463.43M |
| Mar 31, 2025 | 222 | 34 | 35 | 58 | 70 | 56 | 227.23M | $260.26M |
| Change | 6(3%) | 31(1033%) | 33(1650%) | 52(867%) | 67(2233%) | 54(2700%) | 37.03M(14%) | $203.16M(44%) |